Open AccessPrevalence of urogenital inflammatory diseases associated with genital mycoplasms. Treatment efficacy
Author(s) -
О. В. Лысенко,
Т. В. Кузнеченкова,
В. А. Игликов,
V P DERYABINA
Publication year - 2010
Publication title -
vestnik dermatologii i venerologii
Language(s) - English
Resource type - Journals
eISSN - 2313-6294
pISSN - 0042-4609
DOI - 10.25208/vdv939
Subject(s) - josamycin , ureaplasma urealyticum , mycoplasma genitalium , ureaplasma , medicine , azithromycin , gynecology , genitourinary system , sex organ , mycoplasma hominis , doxycycline , chlamydia trachomatis , biology , antibiotics , mycoplasma , microbiology and biotechnology , genetics
Examination of 15765 women by PCR or culture method in the Southern Urals revealed genital mycoplasmas (M.hominis, M.genitalium, Ureaplasma spp.) in 25.8% of cases; they were more frequently met among socially non-adapted women (65,9% vs 17,2% in socially adapted group of women). Prescription of Josamycin (Wilprafen®), 500 mg TID for 10 days to women of both social groups provided the high level of antimicrobial effectiveness (92%) and favorable safety profile.